Trusted by 200+ Clients Around The World

For the past 10 years, LIDE (Lab for Innovated Diagnosis and Experimental Therapeutics) has partnered with small biotech companies and multinational pharmaceutical organizations and delivered thousands of projects successfully. LIDE has a global presence and pride itself on strong academic relationships.

LIDE Translational Platform Services

 

 

PDX

LIDE has established 1500+ high quality PDX models in more than 40 cancer types

Read More >

MiniPDX

LIDE’s novel in vivo drug efficacy test is the in vivo version of organoid assay and takes only 7 days.

Read More >

CR

LIDE has developed over 100 CR cells, some with special drug resistance/genetic alteration.

Read More >

 

 

K Cell & FGI

LIDE requires only a small sample to generate visual expression maps of cell functional subpopulations.

Read More >

Pre-clinical indication / bio-marker determination

LIDE’s technology portfolio enables effective indication determination and patient stratification during the pre-clinical stage.

Read More >

Pre-clinical assays from tumors directly from patients

FFPE or cell suspensions prepared from patient tumor tissue can be used to generate multiple pre-clinical assays.

Read More >
Resources

Publications

Discover the latest research that leverage LIDE tools and services.

Read More >

Request a Quote

Get a customized quote based on your specific research needs.

Request a Quote >